Cubist Systematic Strategies, LLC Spring Works Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $131,462 - $258,482	6,941 New	6,941 $253,000
Q1 2023 May 15, 2023	SELL	$24.97 - $34.05 $4.97 Million - $6.78 Million	-199,020 Reduced 92.82%	15,387 $396,000
Q4 2022 Feb 14, 2023	BUY	$21.73 - $28.72 $945,385 - $1.25 Million	43,506 Added 25.46%	214,407 $5.58 Million
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $828,702 - $1.36 Million	34,386 Added 25.19%	170,901 $4.88 Million
Q2 2022 Aug 15, 2022	BUY	$18.36 - $60.07 $2.51 Million - $8.2 Million	136,515 New	136,515 $3.36 Million
Q1 2022 May 16, 2022	SELL	$48.97 - $65.46 $507,818 - $678,820	-10,370 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$53.3 - $75.84 $159,260 - $226,609	-2,988 Reduced 22.37%	10,370 $643,000
Q3 2021 Nov 15, 2021	SELL	$62.66 - $88.26 $598,027 - $842,353	-9,544 Reduced 41.67%	13,358 $847,000
Q2 2021 Aug 16, 2021	SELL	$67.45 - $85.63 $289,630 - $367,695	-4,294 Reduced 15.79%	22,902 $1.89 Million
Q1 2021 May 17, 2021	BUY	$65.1 - $93.59 $956,969 - $1.38 Million	14,700 Added 117.64%	27,196 $2 Million
Q4 2020 Feb 16, 2021	BUY	$48.36 - $77.92 $536,747 - $864,834	11,099 Added 794.49%	12,496 $906,000
Q3 2020 Nov 16, 2020	SELL	$36.14 - $51.99 $38,055 - $54,745	-1,053 Reduced 42.98%	1,397 $67,000
Q2 2020 Aug 14, 2020	BUY	$22.98 - $48.57 $40,720 - $86,066	1,772 Added 261.36%	2,450 $103,000
Q1 2020 May 15, 2020	BUY	$20.44 - $41.21 $13,858 - $27,940	678 New	678 $18,000

238

70M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.34B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.